retatrutide vs tirzepatide Retatrutide vs Tirzepatide: Which Research
Description
Database Design: The tech stack must process massive biometric influxes without lag
Will retatrutide need a cardiovascular outcomes trial before approval
.webp)
Serious adverse events and mortality Incidence of serious adverse events did not differ between any of the tirzepatide doses and any comparator (ESM Table 3)
10.1001/jama.2023.26112 JAMA
2021;43:18121826.e1817
